Skip to main content
Clinical Trials/TCTR20171106003
TCTR20171106003
Recruiting
Phase 4

High flow nasal oxygen for prevention of intubation in acute non-hypercapnic hypoxemic respiratory failure in immunocompromised patients, a randomized trial

Faculty of medicine, Chiang Mai University0 sites74 target enrollmentNovember 6, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Acute hypoxemic respiratory failure due to pneumonia in immunocompromised patients
Sponsor
Faculty of medicine, Chiang Mai University
Enrollment
74
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2017
End Date
August 7, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Faculty of medicine, Chiang Mai University

Eligibility Criteria

Inclusion Criteria

  • all the following
  • 1\.Immunocompromised patients: solid or hematologic malignancy, received immunosuppressive drug or steroid at a dose\> 20 mg/day of prednisolone for \> 30 days, HIV infection
  • 2\.Require nasal low\-flow oxygen of 4 L/min to maintain PaO2 above 60 mmHg or SpO2\> 90% for \> 1 hour
  • 3\.Age \>\= 18 years

Exclusion Criteria

  • 1\.PaCO2\> 45 mmHg
  • 2\.Post\-extubation respiratory failure (respiratory failure within 48 hr after extubation)
  • 3\.Life\-threatening ARF requiring immediate IMV
  • 5\.Active pulmonary tuberculosis
  • 6\.Contraindications to NIV
  • 7\.A do\-not\-intubate order
  • 8\.Patients refused to participate the study

Outcomes

Primary Outcomes

Not specified

Similar Trials